LFG
GSK icon

Larson Financial Group’s GSK GSK Stock Holding History

Larson Financial Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$154K Buy
2,939
+748
+34% +$39.6K ﹤0.01% 961
2026
Q1 		$121K Sell
2,191
-389
-15% -$21.1K ﹤0.01% 913
2025
Q4 		$127K Buy
2,580
+523
+25% +$24.4K ﹤0.01% 851
2025
Q3 		$88.8K Buy
2,057
+464
+29% +$18.1K ﹤0.01% 949
2025
Q2 		$61.2K Buy
1,593
+953
+149% +$36.4K ﹤0.01% 1002
2025
Q1 		$24.8K Sell
640
-215
-25% -$7.87K ﹤0.01% 1284
2024
Q4 		$28.9K Sell
855
-952
-53% -$34.3K ﹤0.01% 1086
2024
Q3 		$73.9K Buy
1,807
+1,519
+527% +$62.1K ﹤0.01% 798
2024
Q2 		$11.1K Sell
288
-797
-73% -$33.5K ﹤0.01% 1230
2024
Q1 		$46.5K Buy
1,085
+200
+23% +$8.25K ﹤0.01% 708
2023
Q4 		$32.8K Hold
885
– – ﹤0.01% 733
2023
Q3 		$32.1K Buy
885
+647
+272% +$23K ﹤0.01% 716
2023
Q2 		$8.5K Sell
238
-390
-62% -$14K ﹤0.01% 981
2023
Q1 		$22.3K Buy
628
+390
+164% +$13.6K ﹤0.01% 714
2022
Q4 		$8.35K Buy
238
+1
+0.4% +$33 ﹤0.01% 915
2022
Q3 		$7K Buy
237
+1
+0.4% +$38 ﹤0.01% 875
2022
Q2 		$13K Buy
236
+2
+0.9% +$110 ﹤0.01% 637
2022
Q1 		$13K Buy
234
+4
+2% +$217 ﹤0.01% 593
2021
Q4 		$13K Buy
230
+2
+0.9% +$104 ﹤0.01% 616
2021
Q3 		$11K Buy
228
+3
+1% +$151 ﹤0.01% 577
2021
Q2 		$11K Buy
225
+3
+1% +$144 ﹤0.01% 533
2021
Q1 		$10K Sell
222
-13
-6% -$590 ﹤0.01% 542
2020
Q4 		$11K Buy
235
+5
+2% +$230 ﹤0.01% 479
2020
Q3 		$11K Buy
230
+41
+22% +$2.05K ﹤0.01% 423
2020
Q2 		$10K Buy
189
+3
+2% +$154 ﹤0.01% 396
2020
Q1 		$9K Buy
186
+2
+1% +$107 0.01% 306
2019
Q4 		$11K Buy
184
+2
+1% +$111 0.01% 286
2019
Q3 		$10K Buy
182
+2
+1% +$103 0.01% 307
2019
Q2 		$9K Buy
180
+2
+1% +$100 0.01% 257
2019
Q1 		$9K Buy
178
+3
+2% +$150 0.01% 245
2018
Q4 		$8K Buy
+175
New +$8.62K 0.01% 240

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Larson Financial Group's GSK Position: Q2 2026 in Review

Larson Financial Group increased its GSK (GSK) stake by 34% in Q2 2026, buying an estimated $39.6K and bringing the position to 2,939 shares worth $154K. The position accounts for ﹤0.01% of the portfolio, ranked #961.

Larson Financial Group first reported a position in GSK in Q4 2018 and has held it in 31 quarters since. 1,043 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Larson Financial Group held 2,939 shares of GSK worth $154K as of Q2 2026.
  • Larson Financial Group bought 748 GSK shares in Q2 2026, an estimated $39.6K.
  • GSK made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #961 holding.
  • Larson Financial Group first reported a position in GSK in Q4 2018 and has held it in 31 quarters since.
  • 1,043 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.